Cargando…

Blood transfusion and the anaesthetist: management of massive haemorrhage

1. Hospitals must have a major haemorrhage protocol in place and this should include clinical, laboratory and logistic responses. 2. Immediate control of obvious bleeding is of paramount importance (pressure, tourniquet, haemostatic dressings). 3. The major haemorrhage protocol must be mobilised imm...

Descripción completa

Detalles Bibliográficos
Autores principales: Thomas, D, Wee, M, Clyburn, P, Walker, I, Brohi, K, Collins, P, Doughty, H, Isaac, J, Mahoney, PF, Shewry, L
Formato: Texto
Lenguaje:English
Publicado: Blackwell Publishing Ltd 2010
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3032944/
https://www.ncbi.nlm.nih.gov/pubmed/20963925
http://dx.doi.org/10.1111/j.1365-2044.2010.06538.x
_version_ 1782197516955025408
author Thomas, D
Wee, M
Clyburn, P
Walker, I
Brohi, K
Collins, P
Doughty, H
Isaac, J
Mahoney, PF
Shewry, L
author_facet Thomas, D
Wee, M
Clyburn, P
Walker, I
Brohi, K
Collins, P
Doughty, H
Isaac, J
Mahoney, PF
Shewry, L
author_sort Thomas, D
collection PubMed
description 1. Hospitals must have a major haemorrhage protocol in place and this should include clinical, laboratory and logistic responses. 2. Immediate control of obvious bleeding is of paramount importance (pressure, tourniquet, haemostatic dressings). 3. The major haemorrhage protocol must be mobilised immediately when a massive haemorrhage situation is declared. 4. A fibrinogen < 1 g.l(−1) or a prothrombin time (PT) and activated partial thromboplastin time (aPTT) of > 1.5 times normal represents established haemostatic failure and is predictive of microvascular bleeding. Early infusion of fresh frozen plasma (FFP; 15 ml.kg(−1)) should be used to prevent this occurring if a senior clinician anticipates a massive haemorrhage. 5. Established coagulopathy will require more than 15 ml.kg(−1) of FFP to correct. The most effective way to achieve fibrinogen replacement rapidly is by giving fibrinogen concentrate or cryoprecipitate if fibrinogen is unavailable. 6. 1:1:1 red cell:FFP:platelet regimens, as used by the military, are reserved for the most severely traumatised patients. 7. A minimum target platelet count of 75 × 10(9).l(−1) is appropriate in this clinical situation. 8. Group-specific blood can be issued without performing an antibody screen because patients will have minimal circulating antibodies. O negative blood should only be used if blood is needed immediately. 9. In hospitals where the need to treat massive haemorrhage is frequent, the use of locally developed shock packs may be helpful. 10. Standard venous thromboprophylaxis should be commenced as soon as possible after haemostasis has been secured as patients develop a prothrombotic state following massive haemorrhage.
format Text
id pubmed-3032944
institution National Center for Biotechnology Information
language English
publishDate 2010
publisher Blackwell Publishing Ltd
record_format MEDLINE/PubMed
spelling pubmed-30329442011-02-15 Blood transfusion and the anaesthetist: management of massive haemorrhage Thomas, D Wee, M Clyburn, P Walker, I Brohi, K Collins, P Doughty, H Isaac, J Mahoney, PF Shewry, L Anaesthesia Guidelines 1. Hospitals must have a major haemorrhage protocol in place and this should include clinical, laboratory and logistic responses. 2. Immediate control of obvious bleeding is of paramount importance (pressure, tourniquet, haemostatic dressings). 3. The major haemorrhage protocol must be mobilised immediately when a massive haemorrhage situation is declared. 4. A fibrinogen < 1 g.l(−1) or a prothrombin time (PT) and activated partial thromboplastin time (aPTT) of > 1.5 times normal represents established haemostatic failure and is predictive of microvascular bleeding. Early infusion of fresh frozen plasma (FFP; 15 ml.kg(−1)) should be used to prevent this occurring if a senior clinician anticipates a massive haemorrhage. 5. Established coagulopathy will require more than 15 ml.kg(−1) of FFP to correct. The most effective way to achieve fibrinogen replacement rapidly is by giving fibrinogen concentrate or cryoprecipitate if fibrinogen is unavailable. 6. 1:1:1 red cell:FFP:platelet regimens, as used by the military, are reserved for the most severely traumatised patients. 7. A minimum target platelet count of 75 × 10(9).l(−1) is appropriate in this clinical situation. 8. Group-specific blood can be issued without performing an antibody screen because patients will have minimal circulating antibodies. O negative blood should only be used if blood is needed immediately. 9. In hospitals where the need to treat massive haemorrhage is frequent, the use of locally developed shock packs may be helpful. 10. Standard venous thromboprophylaxis should be commenced as soon as possible after haemostasis has been secured as patients develop a prothrombotic state following massive haemorrhage. Blackwell Publishing Ltd 2010-11 /pmc/articles/PMC3032944/ /pubmed/20963925 http://dx.doi.org/10.1111/j.1365-2044.2010.06538.x Text en Copyright © 2010 The Association of Anaesthetists of Great Britain and Ireland http://creativecommons.org/licenses/by/2.5/ Re-use of this article is permitted in accordance with the Creative Commons Deed, Attribution 2.5, which does not permit commercial exploitation.
spellingShingle Guidelines
Thomas, D
Wee, M
Clyburn, P
Walker, I
Brohi, K
Collins, P
Doughty, H
Isaac, J
Mahoney, PF
Shewry, L
Blood transfusion and the anaesthetist: management of massive haemorrhage
title Blood transfusion and the anaesthetist: management of massive haemorrhage
title_full Blood transfusion and the anaesthetist: management of massive haemorrhage
title_fullStr Blood transfusion and the anaesthetist: management of massive haemorrhage
title_full_unstemmed Blood transfusion and the anaesthetist: management of massive haemorrhage
title_short Blood transfusion and the anaesthetist: management of massive haemorrhage
title_sort blood transfusion and the anaesthetist: management of massive haemorrhage
topic Guidelines
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3032944/
https://www.ncbi.nlm.nih.gov/pubmed/20963925
http://dx.doi.org/10.1111/j.1365-2044.2010.06538.x
work_keys_str_mv AT thomasd bloodtransfusionandtheanaesthetistmanagementofmassivehaemorrhage
AT weem bloodtransfusionandtheanaesthetistmanagementofmassivehaemorrhage
AT clyburnp bloodtransfusionandtheanaesthetistmanagementofmassivehaemorrhage
AT walkeri bloodtransfusionandtheanaesthetistmanagementofmassivehaemorrhage
AT brohik bloodtransfusionandtheanaesthetistmanagementofmassivehaemorrhage
AT collinsp bloodtransfusionandtheanaesthetistmanagementofmassivehaemorrhage
AT doughtyh bloodtransfusionandtheanaesthetistmanagementofmassivehaemorrhage
AT isaacj bloodtransfusionandtheanaesthetistmanagementofmassivehaemorrhage
AT mahoneypf bloodtransfusionandtheanaesthetistmanagementofmassivehaemorrhage
AT shewryl bloodtransfusionandtheanaesthetistmanagementofmassivehaemorrhage
AT bloodtransfusionandtheanaesthetistmanagementofmassivehaemorrhage